Validation Of The Transthyretin Amyloidosis Cardiomyopathy Score In A Black And Hispanic Screening Population: An Interim Analysis Of The First 342 Cases From The Scan-mp Study

The transthyretin amyloidosis cardiomyopathy (ATTR-CM) score was developed at the Mayo Clinic to identify high-risk patients for ATTR-CM. However, its performance in populations comprised of minoritized patients is unknown.

Source: Journal of Cardiac Failure - January 1, 2024 Category: Cardiology Authors: Nicholas Chan, Andrew Einstein, Sergio Teruya, Carlos Rodriguez, Stephen Helmke, Margaret Cuomo, Albert DeLuca, Lynne Johnson, Mona Kinkhabwala, Denisse Santana, Michelle Castillo, Dia Smiley, Natalia Sabogal, Sendy Lamour, Morgan Winburn, Denise Fine, Ci Tags: 112 Source Type: research